-
-
-
-
-
-
-
RadioMedix names former Lantheus CEO to its board of directors
-
-
-
-
-
-
-
Lantheus licenses prostate cancer imaging agent to GE HealthCare for Japan
-
-
-
-
-
-
-
Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Lantheus Holdings (LNTH) to Acquire Evergreen Theragnostics for Upfront Payment of $250M
-
-
-
-
-
-
-
Lantheus Appoints Julie Eastland as New Board Member
-
-
-
-
-
-
-
Lantheus Holdings (LNTH) Acquires Manufacturing Facility
-
-
-
-
-
-
-
Perspective Therapeutics Enters into Strategic Agreements with Lantheus Including Equity Investment, Co-Development Options, and Expansion of Manufacturing Capability
-
1,179,750 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

